Credit Suisse Group Raises ConvaTec Group (OTCMKTS:CNVVY) Price Target to GBX 225

ConvaTec Group (OTCMKTS:CNVVY – Get Rating) had its target price raised by Credit Suisse Group from GBX 220 ($2.74) to GBX 225 ($2.80) in a report published on Tuesday morning, The Fly reports.

A number of other equities research analysts also recently issued reports on CNVVY. Sanford C. Bernstein began coverage on shares of ConvaTec Group in a report on Tuesday, March 7th. They issued an outperform rating on the stock. JPMorgan Chase & Co. upped their price objective on shares of ConvaTec Group from GBX 281 ($3.50) to GBX 305 ($3.79) in a research report on Friday, March 10th. Finally, Barclays upped their price objective on shares of ConvaTec Group from GBX 295 ($3.67) to GBX 300 ($3.73) in a research report on Friday, May 19th. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of Moderate Buy and a consensus target price of $266.25.

ConvaTec Group Price Performance

Shares of ConvaTec Group stock opened at $10.69 on Tuesday. ConvaTec Group has a 12-month low of $8.69 and a 12-month high of $12.23. The company’s 50-day moving average price is $10.70 and its 200-day moving average price is $11.03.

ConvaTec Group Increases Dividend

The business also recently disclosed a dividend, which will be paid on Friday, June 9th. Stockholders of record on Tuesday, April 11th will be paid a dividend of $0.1396 per share. This represents a dividend yield of 1.85%. The ex-dividend date of this dividend is Monday, April 10th. This is a positive change from ConvaTec Group’s previous dividend of $0.05.

ConvaTec Group Company Profile

(Get Rating)

ConvaTec Group Plc operates as holding company, which engages in medical business. Its activities include development, manufacture and sales of medical products and technologies related to therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care and management, continence and critical care, and infusion devices used in the treatment of diabetes and other conditions.